Stock PHAR PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Pharming Group N.V. Nasdaq

Equities

PHAR

US71716E1055

Delayed Nasdaq
Other stock markets
 09:34:29 20/06/2024 pm IST 		5-day change 1st Jan Change
8.245 USD -3.54% Intraday chart for Pharming Group N.V. -4.21% -27.95%
31/05 Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug MT
30/05 Pharming Group N.V. Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of Apds in the European Union CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. PHAR Stock
  5. Revisions Pharming Group N.V.